Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents describe new treatment options for diabetes

May 9, 2007

Rare Disease Therapeutics to market Cystadane in U.S. and Canada

May 9, 2007

Novel therapeutic options for metabolic disorders described in recent patents

May 8, 2007

6R-BH4 enters phase IIa study for sickle cell disease

May 7, 2007

NGD-4715 for obesity completes first-in-man study

May 7, 2007

Recent patent from Astellas describes novel xanthine oxidase inhibitors

May 7, 2007

Supprelin-LA approved for central precocious puberty

May 4, 2007

Phase Ib study to begin for optimized TPM-02/Insulin

May 4, 2007

Recent patents describe new antidiabetic agents

May 3, 2007

Soliris recommended for European approval in PNH

May 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...